Apolipoprotein C-II deficiency with no rare variant in the APOC2 gene

Journal of Atherosclerosis and Thrombosis

Volumn 20, Issue 5, 2013, Pages 481-493

  Takase, Satoru ^a   Osuga, Jun Ichi ^b   Fujita, Hayato ^a   Hara, Kazuo ^a   Sekiya, Motohiro ^a   Igarashi, Masaki ^a   Takanashi, Mikio ^a   Takeuchi, Yoshinori ^a   Izumida, Yoshihiko ^a   Ohta, Keisuke ^a   Kumagai, Masayoshi ^a   Nishi, Makiko ^a   Kubota, Midori ^a   Masuda, Yukari ^a   Taira, Yoshino ^a   Okazaki, Sachiko ^a   Iizuka, Yoko ^a   Yahagi, Naoya ^a   Ohashi, Ken ^a   Yoshida, Hiroshi ^c   Yanai, Hidekatsu ^c   Tada, Norio ^c   Gotoda, Takanari ^d   Ishibashi, Shun ^b   Kadowaki, Takashi ^a   Okazaki, Hiroaki ^a   more..

^a UNIVERSITY OF TOKYO   (Japan)

^b JICHI MEDICAL UNIVERSITY   (Japan)

^c JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d UNIVERSITY OF TOKYO HOSPITAL   (Japan)

Author keywords

Apolipoprotein C II deficiency; Chylomicronemia; Cis regulatory region; Rare variant; Single nucleotide polymorphism

Indexed keywords

APOLIPOPROTEIN C2; GENOMIC DNA; LIPOPROTEIN LIPASE; LUCIFERASE; N (2, 2, 2 TRIFLUOROETHYL) N [4 [2, 2, 2 TRIFLUORO 1 HYDROXY 1 (TRIFLUOROMETHOXY) ETHYL] PHENYL] BENZENESULFONAMIDE; PROTEIN VARIANT; TRIACYLGLYCEROL; TRIACYLGLYCEROL LIPASE; UNCLASSIFIED DRUG;

ADULT; APOLIPOPROTEIN C2 GENE; ARTICLE; CHEMICAL ANALYSIS; CONTROLLED STUDY; FEMALE; GENE; GENE SEQUENCE; GENETIC ANALYSIS; GENOTYPE; HUMAN; HUMAN CELL; HYPERTRIGLYCERIDEMIA; IMMUNOBLOTTING; ISOELECTRIC FOCUSING; MALE; METABOLISM; MUTATION; NORTHERN BLOTTING; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REPORTER GENE; RNA SPLICING; RNA TRANSCRIPTION; SINGLE NUCLEOTIDE POLYMORPHISM; SOUTHERN BLOTTING;

APOLIPOPROTEIN C-II; DNA COPY NUMBER VARIATIONS; DNA MUTATIONAL ANALYSIS; HUMANS; HYPERLIPOPROTEINEMIA TYPE I; LIPOPROTEIN LIPASE; MALE; MIDDLE AGED; MONOCYTES; POLYMORPHISM, SINGLE NUCLEOTIDE; RNA, MESSENGER; SEQUENCE ANALYSIS, DNA; TRIGLYCERIDES;

EID: 84878410932     PISSN: 13403478     EISSN: 18803873     Source Type: Journal    
DOI: 10.5551/jat.16592     Document Type: Article

References (32)

1. Nordestgaard BG, Benn M, Schnohr P, Tybjaerg-Hansen A: Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women. JAMA, 2007; 298: 299-308
2. Bansal S, Buring JE, Rifai N, Mora S, Sacks FM, Ridker PM: Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women. JAMA, 2007; 298: 309-316
3. Sarwar N, Sandhu MS, Ricketts SL, Butterworth AS, Di Angelantonio E, Boekholdt SM, Ouwehand W, Watkins H, Samani NJ, Saleheen D, Lawlor D, Reilly MP, Hingorani AD, Talmud PJ, Danesh J: Triglyceride-mediated pathways and coronary disease: collaborative analysis of 101 studies. Lancet, 2010; 375: 1634-1639
4. Kane JP, Havel RJ: Structure and Metabolism of Plasma Lipoproteins. In: The Online Metabolic & Molecular Basis of Inherited Disease 8 th Ed, ed by Scriver CR, Beaudet AL, Valle D and Sly WS., McGraw-Hill, New York, 2001
5. Larosa JC, Levy RI, Herbert P, Lux SE, Fredrickson DS: A specific apoprotein activator for lipoprotein lipase. Biochem Biophys Res Commun, 1970; 41: 57-62
6. Brunzell JD, Deeb SS: Familial lipoprotein lipase deficiency, apo C-II deficiency, and hepatic lipase deficiency. In: The Online Metabolic & Molecular Basis of Inherited Disease 8 th Ed, ed by Scriver CR, Beaudet AL, Valle D and Sly WS., McGraw-Hill, New York, 2001
7. Breckenridge WC, Little JA, Steiner G, Chow A, Poapst M: Hypertriglyceridemia associated with deficiency of apolipoprotein C-II. N Engl J Med, 1978; 298: 1265-1273
8. Cox DW, Breckenridge WC, Little JA: Inheritance of apolipoprotein C-II deficiency with hypertriglyceridemia and pancreatitis. N Engl J Med, 1978; 299: 1421-1424
9. Yamamura T, Sudo H, Ishikawa K, Yamamoto A: Familial type I hyperlipoproteinemia caused by apolipoprotein C-II deficiency. Atherosclerosis, 1979; 34: 53-65
10. Wei CF, Tsao YK, Robberson DL, Gotto AM Jr, Brown K, Chan L: The structure of the human apolipoprotein C-II gene. Electron microscopic analysis of RNA:DNA hybrids, complete nucleotide sequence, and identification of 5' homologous sequences among apolipoprotein genes. J Biol Chem, 1985; 260: 15211-15221
11. Fojo SS, De Gennes JL, Chapman J, Parrott C, Lohse P, Kwan SS, Truffert J, Brewer HB Jr: An initiation codon mutation in the apoC-II gene (apoC-II Paris) of a patient with a deficiency of apolipoprotein C-II. J Biol Chem, 1989; 264: 20839-20842
12. Fojo SS, Lohse P, Parrott C, Baggio G, Gabelli C, Thomas F, Hoffman J, Brewer HB Jr: A nonsense mutation in the apolipoprotein C-IIPadova gene in a patient with apolipoprotein C-II deficiency. J Clin Invest, 1989; 84: 1215-1219
13. Connelly PW, Maguire GF, Hofmann T, Little JA: Structure of apolipoprotein C-IIToronto, a nonfunctional human apolipoprotein. Proc Natl Acad Sci U S A, 1987; 84: 270-273
14. Inadera H, Hibino A, Kobayashi J, Kanzaki T, Shirai K, Yukawa S, Saito Y, Yoshida S: A missense mutation (Trp 26-->Arg) in exon 3 of the apolipoprotein CII gene in a patient with apolipoprotein CII deficiency (apo CII-Wakayama). Biochem Biophys Res Commun, 1993; 193: 1174-1183
15. Jong MC, Hofker MH, Havekes LM: Role of ApoCs in lipoprotein metabolism: functional differences between ApoC1, ApoC2, and ApoC3. Arterioscler Thromb Vasc Biol, 1999; 19: 472-484
16. Kei AA, Filippatos TD, Tsimihodimos V, Elisaf MS: A review of the role of apolipoprotein C-II in lipoprotein metabolism and cardiovascular disease. Metabolism, 2012; 61: 906-921
17. Fojo SS, Beisiegel U, Beil U, Higuchi K, Bojanovski M, Gregg RE, Greten H, Brewer HB Jr: Donor splice site mutation in the apolipoprotein (Apo) C-II gene (Apo C-IIHamburg) of a patient with Apo C-II deficiency. J Clin Invest, 1988; 82: 1489-1494
18. Okubo M, Hasegawa Y, Aoyama Y, Murase T: A G +1 to C mutation in a donor splice site of intron 2 in the apolipoprotein (apo) C-II gene in a patient with apo C-II deficiency. A possible interaction between apo C-II deficiency and apo E4 in a severely hypertriglyceridemic patient. Atherosclerosis, 1997; 130: 153-160
19. Streicher R, Geisel J, Weisshaar C, Avci H, Oette K, Muller-Wieland D, Krone W: A single nucleotide substitution in the promoter region of the apolipoprotein C-II gene identified in individuals with chylomicronemia. J Lipid Res, 1996; 37: 2599-2607
20. Yanai H, Tada N, Yoshida H, Tomono Y: Diacylglycerol oil for apolipoprotein C-II deficiency. QJM, 2007; 100: 247-248
21. Murase T, Yamada N, Ohsawa N, Kosaka K, Morita S, Yoshida S: Decline of postheparin plasma lipoprotein lipase in acromegalic patients. Metabolism, 1980; 29: 666-672
22. Gotoda T, Yamada N, Kawamura M, Kozaki K, Mori N, Ishibashi S, Shimano H, Takaku F, Yazaki Y, Furuichi Y, Et Al: Heterogeneous mutations in the human lipoprotein lipase gene in patients with familial lipoprotein lipase deficiency. J Clin Invest, 1991; 88: 1856-1864
23. Okazaki H, Osuga J, Tsukamoto K, Isoo N, Kitamine T, Tamura Y, Tomita S, Sekiya M, Yahagi N, Iizuka Y, Ohashi K, Harada K, Gotoda T, Shimano H, Kimura S, Nagai R, Yamada N, Ishibashi S: Elimination of cholesterol ester from macrophage foam cells by adenovirusmediated gene transfer of hormone-sensitive lipase. J Biol Chem, 2002; 277: 31893-31899
24. Shimano H, Yahagi N, Amemiya-Kudo M, Hasty AH, Osuga J, Tamura Y, Shionoiri F, Iizuka Y, Ohashi K, Harada K, Gotoda T, Ishibashi S, Yamada N: Sterol regulatory element-binding protein-1 as a key transcription factor for nutritional induction of lipogenic enzyme genes. J Biol Chem, 1999; 274: 35832-35839
25. Surendran RP, Visser ME, Heemelaar S, Wang J, Peter J, Defesche JC, Kuivenhoven JA, Hosseini M, Peterfy M, Kastelein JJ, Johansen CT, Hegele RA, Stroes ES, Dallinga-Thie GM: Mutations in LPL, APOC2, APOA5, GPIHBP1 and LMF1 in patients with severe hypertriglyceridaemia. J Intern Med, 2012; 272: 185-196
26. Liu H, Labeur C, Xu CF, Ferrell R, Lins L, Brasseur R, Rosseneu M, Weiss KM, Humphries SE, Talmud PJ: Characterization of the lipid-binding properties and lipoprotein lipase inhibition of a novel apolipoprotein C-III variant Ala23Thr. J Lipid Res, 2000; 41: 1760-1771
27. Sakurabayashi I, Saito Y, Kita T, Matsuzawa Y, Goto Y: Reference intervals for serum apolipoproteins A-I, A-II, B, C-II, C-III, and E in healthy Japanese determined with a commercial immunoturbidimetric assay and effects of sex, age, smoking, drinking, and Lp(a) level. Clin Chim Acta, 2001; 312: 87-95
28. Breckenridge WC, Alaupovic P, Cox DW, Little JA: Apolipoprotein and lipoprotein concentrations in familial apolipoprotein C-II deficiency. Atherosclerosis, 1982; 44: 223-235
29. Mak PA, Laffitte BA, Desrumaux C, Joseph SB, Curtiss LK, Mangelsdorf DJ, Tontonoz P, Edwards PA: Regulated expression of the apolipoprotein E/C-I/C-IV/C-II gene cluster in murine and human macrophages. A critical role for nuclear liver X receptors α and β. J Biol Chem, 2002; 277: 31900-31908
30. Fredrickson DS, Goldstein JL, Brown MS: The familial hyperlipoproteinemias. In: The Metabolic Basis of Inherited Disease, 4 th Ed, ed by Stanbury JB, Wyngaarden JB and Fredrickson DS, pp 604-605. McGraw-Hill, New York, 1978
31. Kawano M, Kodama K, Inadera H, Saito Y, Saito M, Yaginuma T, Kanazawa Y, Kawakami M: A case of apolipoprotein C-II deficiency with coronary artery disease. Clin Exp Med, 2002; 2: 29-31
32. Ghiselli G, Schaefer EJ, Zech LA, Gregg RE, Brewer HB Jr: Increased prevalence of apolipoprotein E4 in type V hyperlipoproteinemia. J Clin Invest, 1982; 70: 474-477